Roche Holding AG
Roche Holding AG earns a Gold tier designation with a score of 77.1, reflecting a credible climate-strategy but under-instrumented finance-governance profile. Roche is the first pharmaceutical company globally with SBTi-validated net-zero (2045) and absolute zero (2050) targets. Strong operational decarbonisation trajectory (-69% Scope 1+2 since 2004, 86% renewable electricity) and comprehensive TCFD disclosure. However, financial controls are weak for a company of this size: no internal carbon price (only exploring), no green bonds or sustainability-linked financing, and no carbon tax integration. ISO 14001/50001 not evidenced across manufacturing sites. P3 at Level 3 is the key downgrade — systems-evidence gap in climate-finance architecture despite strong operational ambition. Swiss jurisdiction limits EU Taxonomy and CSRD disclosure. Four redlines applied: P1 L5 to L4, P3 L4 to L3, P4 L5 to L4, P7 L5 to L4.
Technical assessment based on primary disclosures
Primary Data Source
Assurance Verification
Benchmarking Confidence
Pillar Performance
Assessment
Pillar Performance
Governance Chassis
Data Infrastructure
Financial Controls
Operational Linkage
Risk Radar
Assurance Depth
Transparency & Disclosure
Index Disclaimer
RECI public scores are benchmark indicators derived from our interpretation of publicly available evidence at the time of review. They are not credit ratings, ESG ratings, certifications, or assurance statements. Scores reflect the four-stage governance process: AI analyst draft, senior ESG practitioner review, final record approval, and management calibration.